APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urological Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Urological Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchUrological Medications Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Urological Medications Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Urological Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urological Medications Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Urological Medications Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Urological Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Urological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Urological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Urological Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Urological Medications include Abbott, Novartis, Merck, Lilly, Pfizer, GlaxoSmithKline, AbbVie, Viatris and Sanofi-aventis U.S. LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Urological Medications market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Urological Medications and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Urological Medications revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Urological Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Urological Medications Segment by Company

Abbott

Novartis

Merck

Lilly

Pfizer

GlaxoSmithKline

AbbVie

Viatris

Sanofi-aventis U.S. LLC

Piramal Pharma Solutions

Mallinckrodt

Endo International

Bayer HealthCare Pharmaceuticals

Astellas Pharma

ADVANZ PHARMA

Urological Medications Segment by Type

Anticholinergics

Alpha Blockers

5-Alpha Inhibitors

Others

Urological Medications Segment by Application

OAB

ED

Prostate Cancer

BPH

SUI

Others

Urological Medications Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urological Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urological Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urological Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Urological Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Urological Medications industry.

Chapter 3: Detailed analysis of Urological Medications companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urological Medicationsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Urological Medications Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Anticholinergics Table 3. Key Players of Alpha Blockers Table 4. Key Players of 5-Alpha Inhibitors Table 3. Key Players of Others Table 4. Global Urological Medications Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of OAB Table 6. Key Players of ED Table 7. Key Players of Prostate Cancer Table 8. Key Players of BPH Table 9. Key Players of SUI Table 10. Key Players of Others Table 11. Global Urological Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Urological Medications Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Urological Medications Market Share by Region (2021-2026) Table 14. Global Urological Medications Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Urological Medications Market Share by Region (2027-2032) Table 16. Urological Medications Industry Trends Table 17. Urological Medications Industry Drivers Table 18. Urological Medications Industry Opportunities and Challenges Table 19. Urological Medications Industry Restraints Table 20. Global Urological Medications Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Urological Medications Revenue Market Share by Company (2021-2026) Table 22. Global Urological Medications Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Urological Medications Key Company Head Office and Area Served Table 24. Global Urological Medications Company, Product Type & Application Table 25. Global Urological Medications Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Urological Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Urological Medications Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Urological Medications Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Urological Medications Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Urological Medications Revenue Market Share by Type (2021-2026) Table 32. Global Urological Medications Revenue Market Share by Type (2027-2032) Table 33. Global Urological Medications Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Urological Medications Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Urological Medications Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Urological Medications Revenue Market Share by Application (2021-2026) Table 37. Global Urological Medications Revenue Market Share by Application (2027-2032) Table 38. Abbott Company Information Table 39. Abbott Business Overview Table 40. Abbott Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Abbott Urological Medications Product Portfolio Table 42. Abbott Recent Development Table 43. Novartis Company Information Table 44. Novartis Business Overview Table 45. Novartis Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Novartis Urological Medications Product Portfolio Table 47. Novartis Recent Development Table 48. Merck Company Information Table 49. Merck Business Overview Table 50. Merck Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Merck Urological Medications Product Portfolio Table 52. Merck Recent Development Table 53. Lilly Company Information Table 54. Lilly Business Overview Table 55. Lilly Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Lilly Urological Medications Product Portfolio Table 57. Lilly Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Pfizer Urological Medications Product Portfolio Table 62. Pfizer Recent Development Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. GlaxoSmithKline Urological Medications Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. AbbVie Company Information Table 69. AbbVie Business Overview Table 70. AbbVie Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. AbbVie Urological Medications Product Portfolio Table 72. AbbVie Recent Development Table 73. Viatris Company Information Table 74. Viatris Business Overview Table 75. Viatris Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Viatris Urological Medications Product Portfolio Table 77. Viatris Recent Development Table 78. Sanofi-aventis U.S. LLC Company Information Table 79. Sanofi-aventis U.S. LLC Business Overview Table 80. Sanofi-aventis U.S. LLC Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Sanofi-aventis U.S. LLC Urological Medications Product Portfolio Table 82. Sanofi-aventis U.S. LLC Recent Development Table 83. Piramal Pharma Solutions Company Information Table 84. Piramal Pharma Solutions Business Overview Table 85. Piramal Pharma Solutions Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Piramal Pharma Solutions Urological Medications Product Portfolio Table 87. Piramal Pharma Solutions Recent Development Table 88. Mallinckrodt Company Information Table 89. Mallinckrodt Business Overview Table 90. Mallinckrodt Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Mallinckrodt Urological Medications Product Portfolio Table 92. Mallinckrodt Recent Development Table 93. Endo International Company Information Table 94. Endo International Business Overview Table 95. Endo International Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Endo International Urological Medications Product Portfolio Table 97. Endo International Recent Development Table 98. Bayer HealthCare Pharmaceuticals Company Information Table 99. Bayer HealthCare Pharmaceuticals Business Overview Table 100. Bayer HealthCare Pharmaceuticals Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Bayer HealthCare Pharmaceuticals Urological Medications Product Portfolio Table 102. Bayer HealthCare Pharmaceuticals Recent Development Table 103. Astellas Pharma Company Information Table 104. Astellas Pharma Business Overview Table 105. Astellas Pharma Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. Astellas Pharma Urological Medications Product Portfolio Table 107. Astellas Pharma Recent Development Table 108. ADVANZ PHARMA Company Information Table 109. ADVANZ PHARMA Business Overview Table 110. ADVANZ PHARMA Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. ADVANZ PHARMA Urological Medications Product Portfolio Table 112. ADVANZ PHARMA Recent Development Table 113. North America Urological Medications Market Size by Type (2021-2026) & (US$ Million) Table 114. North America Urological Medications Market Size by Type (2027-2032) & (US$ Million) Table 115. North America Urological Medications Market Size by Application (2021-2026) & (US$ Million) Table 116. North America Urological Medications Market Size by Application (2027-2032) & (US$ Million) Table 117. North America Urological Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Urological Medications Market Size by Country (2021-2026) Table 119. North America Urological Medications Market Size by Country (2027-2032) Table 120. Europe Urological Medications Market Size by Type (2021-2026) & (US$ Million) Table 121. Europe Urological Medications Market Size by Type (2027-2032) & (US$ Million) Table 122. Europe Urological Medications Market Size by Application (2021-2026) & (US$ Million) Table 123. Europe Urological Medications Market Size by Application (2027-2032) & (US$ Million) Table 124. Europe Urological Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Urological Medications Market Size by Country (2021-2026) Table 126. Europe Urological Medications Market Size by Country (2027-2032) Table 127. China Urological Medications Market Size by Type (2021-2026) & (US$ Million) Table 128. China Urological Medications Market Size by Type (2027-2032) & (US$ Million) Table 129. China Urological Medications Market Size by Application (2021-2026) & (US$ Million) Table 130. China Urological Medications Market Size by Application (2027-2032) & (US$ Million) Table 131. Asia Urological Medications Market Size by Type (2021-2026) & (US$ Million) Table 132. Asia Urological Medications Market Size by Type (2027-2032) & (US$ Million) Table 133. Asia Urological Medications Market Size by Application (2021-2026) & (US$ Million) Table 134. Asia Urological Medications Market Size by Application (2027-2032) & (US$ Million) Table 135. Asia Urological Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Asia Urological Medications Market Size by Country (2021-2026) Table 137. Asia Urological Medications Market Size by Country (2027-2032) Table 138. South America, Middle East & Africa Urological Medications Market Size by Type (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Urological Medications Market Size by Type (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Urological Medications Market Size by Application (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Urological Medications Market Size by Application (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Urological Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. South America, Middle East & Africa Urological Medications Market Size by Country (2021-2026) Table 144. South America, Middle East & Africa Urological Medications Market Size by Country (2027-2032) Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Urological Medications Product Image Figure 2. Global Urological Medications Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Urological Medications Market Share by Type: 2025 VS 2032 Figure 4. Anticholinergics Image Figure 5. Alpha Blockers Image Figure 6. 5-Alpha Inhibitors Image Figure 7. Others Image Figure 8. Global Urological Medications Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Urological Medications Market Share by Application: 2025 VS 2032 Figure 10. OAB Image Figure 11. ED Image Figure 12. Prostate Cancer Image Figure 13. BPH Image Figure 14. SUI Image Figure 15. Others Image Figure 16. Global Urological Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Urological Medications Market Size (2021-2032) & (US$ Million) Figure 18. Global Urological Medications Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Urological Medications Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Urological Medications Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Urological Medications Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Urological Medications Revenue Market Share by Type (2021-2032) Figure 25. Global Urological Medications Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Urological Medications Revenue Market Share by Application (2021-2032) Figure 27. North America Urological Medications Market Size (2021-2032) & (US$ Million) Figure 28. North America Urological Medications Market Share by Type (2021-2032) Figure 29. North America Urological Medications Market Share by Application (2021-2032) Figure 30. North America Urological Medications Market Share by Country (2021-2032) Figure 31. United States Urological Medications Market Size (2021-2032) & (US$ Million) Figure 32. Canada Urological Medications Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Urological Medications Market Size (2021-2032) & (US$ Million) Figure 34. Europe Urological Medications Market Size (2021-2032) & (US$ Million) Figure 35. Europe Urological Medications Market Share by Type (2021-2032) Figure 36. Europe Urological Medications Market Share by Application (2021-2032) Figure 37. Europe Urological Medications Market Share by Country (2021-2032) Figure 38. Germany Urological Medications Market Size (2021-2032) & (US$ Million) Figure 39. France Urological Medications Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Urological Medications Market Size (2021-2032) & (US$ Million) Figure 41. Italy Urological Medications Market Size (2021-2032) & (US$ Million) Figure 42. Russia Urological Medications Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Urological Medications Market Size (2021-2032) & (US$ Million) Figure 44. China Urological Medications Market Size (2021-2032) & (US$ Million) Figure 45. China Urological Medications Market Share by Type (2021-2032) Figure 46. China Urological Medications Market Share by Application (2021-2032) Figure 47. Asia Urological Medications Market Size (2021-2032) & (US$ Million) Figure 48. Asia Urological Medications Market Share by Type (2021-2032) Figure 49. Asia Urological Medications Market Share by Application (2021-2032) Figure 50. Asia Urological Medications Market Share by Country (2021-2032) Figure 51. Japan Urological Medications Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Urological Medications Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Urological Medications Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Urological Medications Market Size (2021-2032) & (US$ Million) Figure 55. India Urological Medications Market Size (2021-2032) & (US$ Million) Figure 56. Australia Urological Medications Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Urological Medications Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Urological Medications Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Urological Medications Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Urological Medications Market Share by Country (2021-2032) Figure 61. Brazil Urological Medications Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Urological Medications Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Urological Medications Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Urological Medications Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Urological Medications Market Size (2021-2032) & (US$ Million) Figure 66. UAE Urological Medications Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Urological Medications Market Size (2021-2032) & (US$ Million) Figure 68. Chile Urological Medications Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Anticholinergics
  • Alpha Blockers
  • 5-Alpha Inhibitors
  • Others
Applications
  • OAB
  • ED
  • Prostate Cancer
  • BPH
  • SUI
  • Others
Companies covered
  • Abbott
  • Novartis
  • Merck
  • Lilly
  • Pfizer
  • GlaxoSmithKline
  • AbbVie
  • Viatris
  • Sanofi-aventis U.S. LLC
  • Piramal Pharma Solutions
  • Mallinckrodt
  • Endo International
  • Bayer HealthCare Pharmaceuticals
  • Astellas Pharma
  • ADVANZ PHARMA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Urological Medications Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Anticholinergics
  5. 1.2.3 Alpha Blockers
  6. 1.2.4 5-Alpha Inhibitors
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Urological Medications Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 OAB
  11. 1.3.3 ED
  12. 1.3.4 Prostate Cancer
  13. 1.3.5 BPH
  14. 1.3.6 SUI
  15. 1.3.7 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Urological Medications Growth Trends by Region
  18. 1.5.1 Global Urological Medications Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Urological Medications Market Size by Region (2021-2026)
  20. 1.5.3 Urological Medications Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Urological Medications Market Dynamics
  1. 2.1 Urological Medications Industry Trends
  2. 2.2 Urological Medications Industry Drivers
  3. 2.3 Urological Medications Industry Opportunities and Challenges
  4. 2.4 Urological Medications Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Urological Medications Revenue by Company (2021-2026)
  2. 3.2 Global Urological Medications Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Urological Medications Key Company Head office and Area Served
  4. 3.4 Global Urological Medications Company, Product Type & Application
  5. 3.5 Global Urological Medications Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Urological Medications Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Urological Medications Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Urological Medications Tier 1, Tier 2, and Tier 3
4 Urological Medications Market by Type
  1. 4.1 Global Urological Medications Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Urological Medications Market Size by Type (2021-2032)
  3. 4.3 Global Urological Medications Market Size Share by Type (2021-2032)
5 Urological Medications Market by Application
  1. 5.1 Global Urological Medications Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Urological Medications Market Size by Application (2021-2032)
  3. 5.3 Global Urological Medications Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott Urological Medications Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis Urological Medications Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck Urological Medications Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Lilly
  20. 6.4.1 Lilly Company Information
  21. 6.4.2 Lilly Business Overview
  22. 6.4.3 Lilly Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Lilly Urological Medications Product Portfolio
  24. 6.4.5 Lilly Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pfizer Urological Medications Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GlaxoSmithKline Urological Medications Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AbbVie Urological Medications Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Viatris Urological Medications Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Sanofi-aventis U.S. LLC
  50. 6.9.1 Sanofi-aventis U.S. LLC Company Information
  51. 6.9.2 Sanofi-aventis U.S. LLC Business Overview
  52. 6.9.3 Sanofi-aventis U.S. LLC Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sanofi-aventis U.S. LLC Urological Medications Product Portfolio
  54. 6.9.5 Sanofi-aventis U.S. LLC Recent Developments
  55. 6.10 Piramal Pharma Solutions
  56. 6.10.1 Piramal Pharma Solutions Company Information
  57. 6.10.2 Piramal Pharma Solutions Business Overview
  58. 6.10.3 Piramal Pharma Solutions Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Piramal Pharma Solutions Urological Medications Product Portfolio
  60. 6.10.5 Piramal Pharma Solutions Recent Developments
  61. 6.11 Mallinckrodt
  62. 6.11.1 Mallinckrodt Company Information
  63. 6.11.2 Mallinckrodt Business Overview
  64. 6.11.3 Mallinckrodt Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Mallinckrodt Urological Medications Product Portfolio
  66. 6.11.5 Mallinckrodt Recent Developments
  67. 6.12 Endo International
  68. 6.12.1 Endo International Company Information
  69. 6.12.2 Endo International Business Overview
  70. 6.12.3 Endo International Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Endo International Urological Medications Product Portfolio
  72. 6.12.5 Endo International Recent Developments
  73. 6.13 Bayer HealthCare Pharmaceuticals
  74. 6.13.1 Bayer HealthCare Pharmaceuticals Company Information
  75. 6.13.2 Bayer HealthCare Pharmaceuticals Business Overview
  76. 6.13.3 Bayer HealthCare Pharmaceuticals Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Bayer HealthCare Pharmaceuticals Urological Medications Product Portfolio
  78. 6.13.5 Bayer HealthCare Pharmaceuticals Recent Developments
  79. 6.14 Astellas Pharma
  80. 6.14.1 Astellas Pharma Company Information
  81. 6.14.2 Astellas Pharma Business Overview
  82. 6.14.3 Astellas Pharma Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Astellas Pharma Urological Medications Product Portfolio
  84. 6.14.5 Astellas Pharma Recent Developments
  85. 6.15 ADVANZ PHARMA
  86. 6.15.1 ADVANZ PHARMA Company Information
  87. 6.15.2 ADVANZ PHARMA Business Overview
  88. 6.15.3 ADVANZ PHARMA Urological Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 ADVANZ PHARMA Urological Medications Product Portfolio
  90. 6.15.5 ADVANZ PHARMA Recent Developments
7 North America
  1. 7.1 North America Urological Medications Market Size (2021-2032)
  2. 7.2 North America Urological Medications Market Size by Type
  3. 7.2.1 North America Urological Medications Market Size by Type (2021-2026)
  4. 7.2.2 North America Urological Medications Market Size by Type (2027-2032)
  5. 7.2.3 North America Urological Medications Market Share by Type (2021-2032)
  6. 7.3 North America Urological Medications Market Size by Application
  7. 7.3.1 North America Urological Medications Market Size by Application (2021-2026)
  8. 7.3.2 North America Urological Medications Market Size by Application (2027-2032)
  9. 7.3.3 North America Urological Medications Market Share by Application (2021-2032)
  10. 7.4 North America Urological Medications Market Size by Country
  11. 7.4.1 North America Urological Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Urological Medications Market Size by Country (2021-2026)
  13. 7.4.3 North America Urological Medications Market Size by Country (2027-2032)
  14. 7.4.4 North America Urological Medications Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Urological Medications Market Size (2021-2032)
  2. 8.2 Europe Urological Medications Market Size by Type
  3. 8.2.1 Europe Urological Medications Market Size by Type (2021-2026)
  4. 8.2.2 Europe Urological Medications Market Size by Type (2027-2032)
  5. 8.2.3 Europe Urological Medications Market Share by Type (2021-2032)
  6. 8.3 Europe Urological Medications Market Size by Application
  7. 8.3.1 Europe Urological Medications Market Size by Application (2021-2026)
  8. 8.3.2 Europe Urological Medications Market Size by Application (2027-2032)
  9. 8.3.3 Europe Urological Medications Market Share by Application (2021-2032)
  10. 8.4 Europe Urological Medications Market Size by Country
  11. 8.4.1 Europe Urological Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Urological Medications Market Size by Country (2021-2026)
  13. 8.4.3 Europe Urological Medications Market Size by Country (2027-2032)
  14. 8.4.4 Europe Urological Medications Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Urological Medications Market Size (2021-2032)
  2. 9.2 China Urological Medications Market Size by Type
  3. 9.2.1 China Urological Medications Market Size by Type (2021-2026)
  4. 9.2.2 China Urological Medications Market Size by Type (2027-2032)
  5. 9.2.3 China Urological Medications Market Share by Type (2021-2032)
  6. 9.3 China Urological Medications Market Size by Application
  7. 9.3.1 China Urological Medications Market Size by Application (2021-2026)
  8. 9.3.2 China Urological Medications Market Size by Application (2027-2032)
  9. 9.3.3 China Urological Medications Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Urological Medications Market Size (2021-2032)
  2. 10.2 Asia Urological Medications Market Size by Type
  3. 10.2.1 Asia Urological Medications Market Size by Type (2021-2026)
  4. 10.2.2 Asia Urological Medications Market Size by Type (2027-2032)
  5. 10.2.3 Asia Urological Medications Market Share by Type (2021-2032)
  6. 10.3 Asia Urological Medications Market Size by Application
  7. 10.3.1 Asia Urological Medications Market Size by Application (2021-2026)
  8. 10.3.2 Asia Urological Medications Market Size by Application (2027-2032)
  9. 10.3.3 Asia Urological Medications Market Share by Application (2021-2032)
  10. 10.4 Asia Urological Medications Market Size by Country
  11. 10.4.1 Asia Urological Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Urological Medications Market Size by Country (2021-2026)
  13. 10.4.3 Asia Urological Medications Market Size by Country (2027-2032)
  14. 10.4.4 Asia Urological Medications Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Urological Medications Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Urological Medications Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Urological Medications Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Urological Medications Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Urological Medications Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Urological Medications Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Urological Medications Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Urological Medications Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Urological Medications Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Urological Medications Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Urological Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Urological Medications Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Urological Medications Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Urological Medications Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst